Form 4/A for NUTX Nutex Health Inc.
Accepted 2022-12-30 00:00:00 ET · period of report 2022-05-09 · accession 0001486189-22-000021 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2022-12-30 | 2022-05-09 | NUTX | Creem Mitchell | Dir | J - Other | — | -21.2K | 0 | -100% | — |
| A | 2022-12-30 | 2022-05-09 | NUTX | Creem Mitchell | Dir | A - Grant | $3.89 | +21.2K | 21.2K | New | +$82.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Restricted Stock | 2022-05-09 | J | D | 21,208 | — | 0 | D | — | — | (F2) The restricted stock award was voided ab initio and the reporting person returned the restricted stock subject to the May 9, 2022 award to the issuer for no consideration and the issuer cancelled such restricted stock. |
| 2 | Common | Restricted Stock | 2022-05-09 | A | A | 21,208 | $3.89 | 21,208 | D | — | — |